Application Nr Approved Date Route Status External Links
ANDA090168 2012-11-28 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage For Use As An Adjunct In The Therapy Of All Forms Of Parkinsonism. Useful Also In The Control Of Extrapyramidal Disorders (except Tardive Dyskinesia – See Precautions ) Due To Neuroleptic Drugs (e.g., Phenothiazines).

All Formulated Excipients (5 Total)

Name Structure Kind Function Status
1. Calcium Phosphate, Dibasic, Anhydrous CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS Molecular
2. Lactose Monohydrate LACTOSE MONOHYDRATE Molecular
3. Anhydrous Lactose ANHYDROUS LACTOSE Molecular
4. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
5. Starch, Corn STARCH, CORN Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Benztropine Mesylate BENZTROPINE MESYLATE ZINC100036536